This site is intended for Healthcare Professionals only

MHRA

hayfever-1280x720

Fluticasone 0.05pc nasal spray reclassified to be available for children aged 12 and over

MHRA reclassifies fluticasone nasal spray as a P medicine for those aged 12 years and over, available from February 2026.

16 Dec 2025 , 1 Min Article

hot-flush-summary

'World first': MHRA approves non-hormonal treatment for hot flushes in menopause

MHRA boasts world first as it approves Lynkuet for vasomotor symptoms in menopause

09 Jul 2025 , 1 Min Article

glp-summary

National investigation launched into ‘skinny jab’ hospitalisations

MHRA launches study as hundreds of GLP-1 users hospitalised

27 Jun 2025 , 1 Min Article

Recall 1280.jpg

Pharmacists urged to stop supplying batches of paracetamol amid contamination fears

The MHRA issued a “precautionary recall” of two batches of Chelonia Healthcare Limited’s Paracetamol 500mg Tablets after discoloured tablets were found in some packs.

10 Jun 2025 , 1 Min Article

weight-loss-medication-new-1280

MHRA updates guidance on anti-obesity jabs amid safety concerns

The National Pharmacy Association said regulations and guidance must "keep pace” with the huge demand for weight loss medicines.

05 Jun 2025 , 1 Min Article

crohns-1280x720

Guselkumab approved for treatment of Crohn’s and ulcerative colitis

Guselkumab already approved for plaque psoriasis and psoriatic arthritis, but studies show it is also effective in moderate to severe Crohn’s disease and UC.

20 May 2025 , 1 Min Article

mhra-1280x720

12 arrested in MHRA crackdown on medicines trafficking

Twelve suspects arrested after dawn raids across the West Midlands and the Northwest of England in MHRA's largest investigation into organised medicines trafficking to date.

29 Apr 2025 , 1 Min Article

buy-now-summary

Illegal websites posing as regulated pharmacies, warns coroner after overdose death

Coroner reports on benzodiazepine death of vulnerable 45-year-old man in Wales

28 Apr 2025 , 1 Min Article

eczema

Nemolizumab approved for prurigo nodularis and atopic dermatitis

Nemolizumab (Nemluvio, Galderma) has been approved by the MHRA for the treatment of two skins conditions.

18 Feb 2025 , 1 Min Article

istock-1387630788

MHRA consults on guidance for mRNA cancer vaccines

The MHRA has launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (cancer vaccines).

04 Feb 2025 , 1 Min Article

medicines-hoarding-1280

MHRA: We investigate and act when intelligence on medicines hoarding comes in

MHRA interim executive director James Pound said: "We proactively take action as information and intelligence is shared with us.”

24 Jan 2025 , 1 Min Article

recall-summary

Quarantine stocks of lidocaine ‘delay spray’, MHRA tells retailers

Leeds manufacturer has been selling lidocaine spray without authorisation

14 Nov 2024 , 1 Min Article

semaglutide-summary

Almost 50 hospitalised after taking weight loss drugs, warns MHRA

MHRA issues GLP-1 receptor agonist warning to pharmacy teams.

24 Oct 2024 , 2 Min Article

poc-1280x720

New regulations allow medicines manufacture at point of care

New regulations mean that products with a very short shelf life, and personalised medicines such as gene therapy, can more easily be made in or near a hospital setting

22 Oct 2024 , 2 Min Article

covid-research-2024-1280

MHRA approves adapted version of Comirnaty Covid vaccine

The MHRA approved two “presentations of the adapted vaccine” after they met its standards of safety, quality, and effectiveness.

11 Oct 2024 , 1 Min Article

approved-1280

MHRA today approves new colorectal cancer medicine

Fruquintinib stops tumours making new blood vessels, which normally provide the tumour with nutrients and oxygen.

20 Sep 2024 , 1 Min Article

Change privacy settings